Engineering
The Science BehindKEMIRIX
A layered clinical reasoning engine, hard-gate safety vetoes, and Africa-native pharmacogenomics — built to work from Nairobi to the most remote clinic on Earth.
Architecture
How KEMIRIX Thinks
Every clinical query passes through multiple validation layers before a recommendation is returned. No single layer can produce an output alone — the system requires convergence across all layers.
Hard-Gate Veto Layer: When a critical safety check triggers — severe drug interaction, known G6PD contraindication, or lethal combination — the system stops. No AI output, no model override. The veto is absolute and cannot be bypassed.
Knowledge Bases
Powered by the World’s Best Biomedical Data
KEMIRIX does not generate its own drug data. It integrates the most authoritative, peer-reviewed, and regulatory-grade biomedical knowledge bases available.
Comprehensive drug interaction & ADR database
Pharmacogenomics knowledge base
Clinical Pharmacogenomics Implementation Consortium guidelines
US FDA adverse event & drug data
Kenya Standard Treatment Guidelines
WHO Anatomical Therapeutic Chemical classification
Side effect resource database
Bioactive molecule data for drug discovery
All data sources are licensed, regularly updated, and validated against published clinical standards.
Africa-Native
Built for African Clinical Reality
KEMIRIX is not a Western CDS tool adapted for Africa. It was engineered from day one for African pharmacogenomics, African patient populations, and African clinical contexts.
G6PD A− Variant Awareness
KEMIRIX flags all medications with known haemolysis risk in G6PD-deficient patients. With 15–25% prevalence in West Africa, this check is not optional — it is non-negotiable.
CYP2D6 African Population Frequencies
Drug metabolism varies significantly by CYP2D6 genotype, and African populations carry variants at frequencies not reflected in Western genomic datasets. KEMIRIX incorporates African-specific frequency tables.
Traditional Medicine Interaction Database
80% of Africans use traditional medicine alongside pharmaceuticals. KEMIRIX is the only CDS platform mapping these interactions at clinical scale — covering African TM, Ayurvedic, and TCM preparations.
Swahili Multilingual Interface
KEMIRIX supports Swahili for clinical workflows and is actively expanding to additional African languages — ensuring no healthcare worker is excluded by language barriers.
Safety
A System Designed to Never Fail Silently
Multi-Layer Validation
Every clinical output passes through independent validation layers. A recommendation can only be returned when all layers converge. Disagreement between layers triggers a review flag, not a guess.
Hard-Gate Veto System
KEMIRIX uses a hard-gate veto system. Certain critical safety checks cannot be overridden by any AI output. If a drug interaction is flagged at the veto tier, the system stops — period. No model confidence score, no override button, no “proceed anyway.” Safety is non-negotiable.
Explainability Built In
Every recommendation includes a reference citation from the underlying knowledge base. Clinicians are never asked to trust a black box — they are shown the evidence and make the final call.
Offline-First
Works Where Internet Doesn’t
KEMIRIX is architected offline-first — meaning core clinical reasoning runs locally on the device. A full drug interaction check, ADR screening, and pharmacogenomics assessment can be completed with zero internet connectivity.
When connectivity is available, the platform synchronises with the cloud, updates its knowledge bases, and backs up clinical records. When it is not, it keeps working. No internet. No problem.
Local inference · Cloud sync when available · Works in rural Africa